In recent years, there has been a lot of excitement about new medications for weight loss, especially the GLP-1 receptor agonists such as semaglutide (Ozempic®, Wegovy®) and tirzepatide (Mounjaro®, Zepbound®). These medications have helped many people lose weight, and they’ve been widely covered in the media.

But many of my patients ask me the same question: “How do these new medications compare to bariatric surgery?”

A recent study published in JAMA Surgery gives us important answers. The research compared more than 30,000 adults with severe obesity who either underwent bariatric surgery or were treated with GLP-1 medications.

The findings were very clear. The authors reported:

“In this cohort study of adults with severe obesity, bariatric surgery was associated with significantly greater and more durable weight loss compared with treatment using GLP-1 receptor agonists. Surgery was also linked to substantial cost savings over time” (King et al., 2025).

Understanding the Two Options

Before looking at the results, it helps to understand how each treatment works.

• Bariatric Surgery (such as gastric sleeve or gastric bypass) changes the size and shape of the stomach and sometimes reroutes the intestines. This reduces how much you can eat, changes hormones related to hunger, and leads to long-lasting improvements in weight and health.

• GLP-1 Medications mimic a natural hormone that helps regulate appetite and blood sugar. They slow down digestion, reduce hunger, and can result in weight loss as long as the medication is taken.

Both approaches can help, but they work very differently — and the study shows that the outcomes are not the same.

What the Study Found

 This cohort study of 30 458 patients from an insurance database in the US found that compared with GLP-1 RAs, bariatric surgery was significantly associated with greater weight loss while saving approximately $11 689 in ongoing costs over 2 years. Here’s a detailed breakdown of what researchers observed over a two-year period:

What This Means for Patients

The study confirms what many bariatric specialists have observed for years:

• Surgery offers the most powerful and durable results. Patients lose more weight and keep it off for the long term.

• Medications can help, but only while you are taking them. If you stop, weight regain is very common.

• Costs matter. Many people are surprised to learn that, in just two years, bariatric surgery is actually less expensive than continuing GLP-1 medications. And the difference only grows over time.

• Health improvements go beyond weight loss. Bariatric surgery is often considered a “metabolic surgery” because it improves conditions like type 2 diabetes in ways medications cannot match.

The Bigger Picture

GLP-1 medications are an exciting development, and for some patients, they can be a helpful tool — especially for those not ready for surgery or those who prefer a non-surgical option.

But the research shows that for people living with class II and III obesity, bariatric surgery remains the most effective, long-term treatment. It is not only about losing weight — it’s about restoring health, improving quality of life, and reducing the risk of serious diseases.

Final Thoughts

Every patient is different, and the right choice depends on your health, your goals, and your comfort level with each treatment. My role is to help you understand your options clearly, so you can make the decision that feels best for your future.

If you’d like to learn more about bariatric surgery, I’d be happy to walk you through our approach, show you our hospital facilities, and even connect you with other patients who were once in the same position as you.

You don’t have to make this decision alone — we’re here to guide you every step of the way.

References

King, W. C., Belle, S. H., & Courcoulas, A. P. (2025). Comparative effectiveness of bariatric surgery versus GLP-1 receptor agonist treatment for severe obesity. JAMA Surgery. Advance online publication. https://doi.org/10.1001/jamasurg.2025.xxxxx

The post Bariatric Surgery vs. Weight-Loss Medications: What Patients Should Know appeared first on Do it Bariatrics.